Therapeutic agent for intervertebral disc degeneration and material for culturing inter vertebral disc cells
US11951231B2 · kind B2 · utility
0Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2019 |
| Grant date | Apr 9, 2024 |
| Priority date | — |
| Expiry date | Jul 31, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic agent for intervertebral disc degeneration that contains LASCol obtained by enzymatically cleaving a terminus of collagen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.